Page 35 - 《中国药房》2021年23期

Anti-inflammatory，anti-proliferative and anti-atheroscle- tial effects of Mas receptor deficiency on cardiac function
rotic effects of quercetin in human in vitro and in vivo and blood pressure in obese male and female mice[J]. Am
models[J]. Atherosclerosis，2011，218（1）：44-52. J Physiol Heart Circ Physiol，2017，312（3）：H459-H468.
[ 9 ] CHEN J Y，HU R Y，CHOU H C. Quercetin-induced cardio- [21] SANTOS R A，CASTRO C H，GAVA E，et al. Impairment
protection against doxorubicin cytotoxicity[J]. J Biomed Sci， of in vitro and in vivo heart function in angiotensin-（1-7）
2013，20（1）：95-101. receptor Mas knockout mice[J]. Hypertension，2006，47
[10] MCKENNA E，SMITH J S，COLL K E，et al. Dissociation （5）：996-1002.
of phospholamban regulation of cardiac sarcoplasmic [22] PARICHATIKANOND W，PINTHONG D，MANGMOOL
reticulum Ca 2 + ATPase by quercetin[J]. J Biol Chem， S，et al. Blockade of the renin-angiotensin system with del-
1996，271（40）：24517-24525. phinidin，cyanin，and quercetin[J]. Planta Med，2012，78
[11] SANTOS R A，CAMPAGNOLE-SANTOS M J，BARACHO （15）：1626-1632.
N C，et al. Characterization of a new angiotensin antago- [23] GRIENDLING K K，LASSÈGUE B，ALEXANDER R W.
nist selective for angiotensin-（1-7）：evidence that the ac- Angiotensin receptors and their therapeutic implica-
tions of angiotensin-（1-7）are mediated by specific angio- tions[J]. Annu Rev Pharmacol Toxicol，1996，36：28l-306.
tensin receptors[J]. Brain Res Bull，1994，35（4）：293-298. [24] YAN L，ZHANG J D，WANG B，et al. Quercetin inhibits
[12] 李彬，王新陆，谢世阳，等.参附益心方对缺氧原代心肌细 left ventricular hypertrophy in spontaneously hypertensive
胞活性氧和能量代谢的影响[J].中国药房，2019，30（8）： rats and inhibits angiotensin Ⅱ-induced H9C2 cells hyper-
1018-1024. trophy by enhancing PPAR-gamma expression and sup-
[13] 杨勇，周勇，佟新竹，等. RNA干扰沉默血管紧张素转化 pressing AP-1 activity[J]. PLoS One，2013，8（9）：e72548.
酶调节血管紧张素 2-血管紧张素 1-7 肽-胞外信号调节 [25] CHEN K X，REKEP M，WEI W，et al. Quercetin prevents
激酶轴改善人脐静脉内皮细胞功能[J].华南国防医学杂 in vivo and in vitro myocardial hypertrophy through the
志，2015，29（7）：507-511. proteasome GSK-3 pathway[J]. Cardiovasc Drugs Ther，
[14] LI T K，ZHANG X W，CHENG H J，et al. Critical role of 2018，32（1）：5-21.
the chymase/angiotensin-（1-12）axis in modulating car- [26] CHEN X，PENG X，LUO Y，et al. Quercetin protects car-
diomyocyte contractility[J]. Int J Cardiol，2018，264： diomyocytes against doxorubicin-induced toxicity by sup-
137-144. pressing oxidative stress and improving mitochondrial
[15] DE MELLO W C. Intracellular angiotensin Ⅱ disrupts function via 14-3-3γ[J]. Toxicol Mech Methods，2019，29
chemical communication and impairs metabolic coopera- （5）：344-354.
tion between cardiac myocytes[J]. Peptides，2015，72：57- [27] JING Z H，WANG Z R，LI X J，et al. Protective effect of
60. quercetin on posttraumatic cardiac injury[J]. Sci Rep，
[16] ZHOU P，CHENG C P，LI T，et al. Modulation of cardiac 2016，6：30812.
L-type Ca 2 + current by angiotensin-（1-7）：normal versus [28] GUO G，GONG L，SUN L，et al. Quercetin supports cell
heart failure[J]. Ther Adv Cardiovasc Dis，2015，9（6）： viability and inhibits apoptosis in cardiocytes by down-
342-353. regulating miR-199a[J]. Artif Cells Nanomed Biotechnol，
[17] CRACKOWER M A，SARAO R，OUDIT G Y，et al. An- 2019，47（1）：2909-2916.
giotensin-converting enzyme 2 is an essential regulator of [29] HAYAMIZU K，MORIMOTO S，NONAKA M，et al. Car-
heart function[J]. Nature，2002，417：822-828. diotonic actions of quercetin and its metabolite tamarixe-
[18] DE MELLO W C. Intracellular angiotensin（1-7）increases tin through a digitalis-like enhancement of Ca transients
2 +
the inward calcium current in cardiomyocytes. On the role [J]. Arch Biochem Biophys，2018，637：40-47.
of PKA activation[J]. Mol Cell Biochem，2015，407（1/2）： [30] SANTOS M S，OLIVEIRA E D，SANTOS-MIRANDA A，
9-16. et al. Dissection of the effects of quercetin on mouse myo-
[19] DIAS-PEIXOTO M F，SANTOS R A，GOMES E R，et al. cardium[J]. Basic Clin Pharmacol Toxicol，2017，120（6）：
Molecular mechanisms involved in the angiotensin-（1-7）/ 550-559.
Mas signaling pathway in cardiomyocytes[J]. Hyperten- （收稿日期：2021-05-15 修回日期：2021-11-08）
sion，2008，52（3）：542-548. （编辑：舒安琴）
[20] WANG Y，SHOEMAKER R，POWELL D，et al. Differen-

中国药房 2021年第32卷第23期 China Pharmacy 2021 Vol. 32 No. 23 ·2845 ·